Jeb Keiper, CEO of Nimbus Therapeutics, on computational drug discovery, an unusual business model, and an important new Tyk2 inhibitor for psoriasis and other forms of autoimmunity.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
